The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity

 A Comprehensive Review.:

Nutr Cancer. 2016 Jun 24;:1-26

Authors: Razavi-Azarkhiavi K, Iranshahy M, Sahebkar A, Shirani K, Karimi G

Abstract

Although doxorubicin (DOX) is among the most widely used anticancer agents, its clinical application is hampered owing to its cardiotoxicity. Adjuvant therapy with an antioxidant has been suggested as a promising strategy to reduce DOX-induced adverse effects. In this context, many phenolic compounds have been reported to protect against DOX-induced cardiotoxicity. The cardioprotective effects of phenolic compounds are exerted via multiple mechanisms including inhibition of reactive oxygen species generation, apoptosis, NF-κB, p53, mitochondrial dysfunction, and DNA damage. In this review, we present a summary of the in vitro, in vivo, and clinical findings on the protective mechanisms of phenolic compounds against DOX-induced cardiotoxicity.

PMID: 27341037 [PubMed - as supplied by publisher]



http://ift.tt/28XwYON